Quality of Life in Psoriasis Vulgaris: Use of the ItchyQoL Question-naire in a Secukinumab Phase III Trial in Patients with Psoriasis Vulgaris

Acta Derm Venereol. 2019 Nov 1;99(12):1085-1090. doi: 10.2340/00015555-3275.

Abstract

Chronic pruritus is a bothersome symptom in psoriasis vulgaris and can profoundly reduce quality of life (QoL). In this exploratory analysis of the PSORITUS study, the impact of pruritus on QoL in 130 subjects with moderate-to-severe psoriasis was assessed using the ItchyQoL questionnaire. The majority of patients (n = 127) had to scratch their itchy skin regularly, which led to painful skin and frustration (mean ± standard deviation; SD ItchyQoL scores; 4.50 ± 0.56; 3.80 ± 1.09 and 4.20 ± 0.87, respectively). Changes in either temperature or season led to a worsening of itching in most of the patients (n = 126; mean ± SD ItchyQoL score; 3.80 ± 1.02). Many patients felt ashamed (n = 125) or embarrassed (n = 127) due to their itchy skin (mean ± SD ItchyQoL scores; 3.90 ± 1.26 and 3.40 ± 1.19, respectively). The results demonstrated the ItchyQoL questionnaire as a validated tool responsive to treatment for detailed insights into chronic pruritus in patients with psoriasis.

Keywords: itch ItchyQoL questionnaire pruritus psoriasis vulgaris quality of life.

Publication types

  • Clinical Trial, Phase III
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Chronic Disease
  • Cost of Illness*
  • Dermatologic Agents / therapeutic use
  • Embarrassment
  • Female
  • Germany
  • Humans
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Pruritus / diagnosis*
  • Pruritus / drug therapy
  • Pruritus / psychology
  • Psoriasis / diagnosis*
  • Psoriasis / drug therapy
  • Psoriasis / psychology
  • Quality of Life*
  • Reproducibility of Results
  • Shame
  • Surveys and Questionnaires*

Substances

  • Antibodies, Monoclonal, Humanized
  • Dermatologic Agents
  • secukinumab